All Stories

  1. Use of renin angiotensin system inhibitors in patients with chronic kidney disease

    Article • Internal Medicine Journal, May 2016, Wiley

    Professor william robert adam

  2. Comment on ‘A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure’

    Article • Diabetic Medicine, October 2015, Wiley

    Professor william robert adam

  3. Renal replacement therapy associated with lithium nephrotoxicity in Australia

    Article • The Medical Journal of Australia, November 2014, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Professor william robert adam

  4. The final arbiter of sodium status and extracellular fluid volume is to assess the response to therapy

    Article • Nephrology, September 2014, Wiley

    Professor william robert adam

  5. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure

    Article • Diabetic Medicine, August 2014, Wiley

    Professor william robert adam

  6. Safety and efficacy of vemurafenib in end stage renal failure

    Article • BMC Cancer, December 2013, Springer Science + Business Media

    Professor william robert adam

  7. Do fluctuations in plasma creatinine/estimated glomerular filtration rate represent a risk factor for mortality?

    Article • Kidney International, October 2013, Elsevier

    Professor william robert adam

  8. Trade‐off between the benefits of lithium treatment and the risk of chronic kidney disease

    Article • Nephrology, October 2012, Wiley

    Professor william robert adam

  9. Utility, or not, of estimates of glomerular filtration rate in modifying drug dosage, with particular reference to enoxaparin

    Article • Internal Medicine Journal, April 2012, Wiley

    Professor william robert adam

  10. Should doctors feel able to practise according to their personal values and beliefs?

    Article • The Medical Journal of Australia, February 2012, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Professor william robert adam

  11. The therapeutic tradeoff between the adverse impacts of a lower GFR and long-term renal protection

    Article • Kidney International, February 2012, Elsevier

    Professor william robert adam

  12. FLUID INTAKE AND CHRONIC KIDNEY DISEASE

    Article • Nephrology, October 2011, Wiley

    Professor william robert adam

  13. Dystopia of using (estimates of) glomerular filtration rate as a trigger for initiating dialysis

    Article • Nephrology, April 2011, Wiley

    Professor william robert adam

  14. Non‐steroidal anti‐inflammatory drugs and the risks of acute renal failure: Number needed to harm

    Article • Nephrology, January 2011, Wiley

    Professor william robert adam

  15. FALSE ALARMS: SUBSTANTIAL SELF‐LIMITING FLUCTUATIONS IN PLASMA CREATININE IN THE ELDERLY WITH STAGE 3 OR 4 RENAL FAILURE

    Article • Nephrology, July 2010, Wiley

    Professor william robert adam

  16. Targeting mineralocorticoid (-like) interventions to treat hyperkalemia in chronic hemodialysis patients

    Article • Kidney International, May 2010, Elsevier

    Professor william robert adam

  17. Hypothesis: A simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemia

    Article • Nephrology, September 2008, Wiley

    Professor william robert adam

  18. INVOLVEMENT OF BOTH THE CLASSICAL AND ALTERNATE PATHWAYS OF COMPLEMENT IN AN EX VIVO MODEL OF XENOGRAFT REJECTION

    Article • Transplantation, April 1997, Wolters Kluwer Health

    Professor william robert adam

  19. Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney

    Article • Kidney International, March 1994, Elsevier

    Professor william robert adam

  20. The use of dietary loading of 133Cs as a potassium substitute in NMR studies of tissues

    Article • Magnetic Resonance in Medicine, November 1993, Wiley

    Professor william robert adam

  21. NMR measurement of 39K detectability and relaxation constants in rat tissue

    Article • Magnetic Resonance in Medicine, January 1993, Wiley

    Professor william robert adam

  22. Progressive Soft Tissue Uptake of Tc-99m MDP Reflecting Metastatic Microcalcification

    Article • Clinical Nuclear Medicine, August 1992, Wolters Kluwer Health

    Professor william robert adam

  23. EFFECTS OF OPIATES ON SODIUM EXCRETION IN THE ISOLATED PERFUSED RAT KIDNEY

    Article • Clinical and Experimental Pharmacology and Physiology, December 1991, Wiley

    Professor william robert adam

  24. Intracellular Compartmentalization of Potassium

    Article • American Journal of Kidney Diseases, October 1989, Elsevier

    Professor william robert adam

  25. POTASSIUM EXCRETION IN RENAL FAILURE IN THE RAT: THE ROLE OF DISTAL TUBULE FLOW AND ALDOSTERONE

    Article • Clinical and Experimental Pharmacology and Physiology, September 1988, Wiley

    Professor william robert adam

  26. Problems in the assessment of magnesium depletion in the rat byin vivo31P NMR

    Article • Magnetic Resonance in Medicine, July 1988, Wiley

    Professor william robert adam

  27. Localization and characterization of renal calcitonin receptors by in vitro autoradiography

    Article • Kidney International, December 1987, Elsevier

    Professor william robert adam

  28. AROMATIC l‐AMINO ACID DECARBOXYLASE: HISTOCHEMICAL LOCALIZATION IN RAT KIDNEY AND LACK OF EFFECT OF DIETARY POTASSIUM OR SODIUM LOADING ON ENZYME DISTRIBUTION

    Article • Clinical and Experimental Pharmacology and Physiology, January 1986, Wiley

    Professor william robert adam

  29. Production and Excretion of Dopamine by the Isolated Perfused Rat Kidney

    Article • Kidney and Blood Pressure Research, January 1985, Karger Publishers

    Professor william robert adam

  30. PLASMA ALDOSTERONE LEVELS AFTER KCI LOADING IN RATS ADAPTED TO A HIGH POTASSIUM DIET

    Article • Clinical and Experimental Pharmacology and Physiology, October 1984, Wiley

    Professor william robert adam

  31. VASCULITIS AND GLOMERULONEPHRITIS: A SUBGROUP WITH AN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY

    Article • Australian and New Zealand Journal of Medicine, June 1984, Wiley

    Professor william robert adam

  32. Adverse Reactions to Long-Term Diuretic Therapy for Hypertension

    Article • Journal of Cardiovascular Pharmacology, January 1984, Wolters Kluwer Health

    Professor william robert adam

  33. Cyproheptadine and Mineralocorticoid Effector Mechanisms

    Article • The Journal of Clinical Endocrinology & Metabolism, February 1983, Endocrine Society

    Professor william robert adam

  34. THE RELATIONSHIP BETWEEN URINARY KALLIKREIN EXCRETION AND MINERALOCORTICOIDS IN THE RAT

    Article • Clinical and Experimental Pharmacology and Physiology, June 1982, Wiley

    Professor william robert adam

  35. Comparison of Oral and Intravenous Radiosulfate Spaces in Dialysis Patients

    Article • January 1982, Karger Publishers

    Professor william robert adam

  36. Metoclopramide Does Not Elevate Aldosterone in the Rat*

    Article • Endocrinology, November 1981, Endocrine Society

    Professor william robert adam

  37. OPIATES INHIBIT THE DOPAMINERGIC ENHANCEMENT OF THE RENAL RESPONSE TO ALDOSTERONE IN THE RAT

    Article • Clinical and Experimental Pharmacology and Physiology, September 1981, Wiley

    Professor william robert adam

  38. 19-NOR PROGESTERONE IS A MINERALOCORTICOID AGONIST

    Article • Endocrinology, July 1981, Endocrine Society

    Professor william robert adam

  39. Orally Active Mineralocorticoid Agonists and Antagonists: Δ1Derivatives of Aldosterone and 18- Deoxyaldosterone*

    Article • Endocrinology, February 1981, Endocrine Society

    Professor william robert adam

  40. Aldosterone and dopamine receptors in the kidney: Sites for pharmacologic manipulation of renal function

    Article • Kidney International, November 1980, Elsevier

    Professor william robert adam

  41. Dopamine and the enhanced renal response to aldosterone in the rat on a high potassium diet

    Article • Clinical and Experimental Pharmacology and Physiology, December 1979, Wiley

    Professor william robert adam

  42. The Mineralocorticoid Antagonist Activity of an 11β, 18-Oxidopregnane*

    Article • Endocrinology, May 1979, Endocrine Society

    Professor william robert adam

  43. Enhancement by L-dopa of the renal action of aldosterone in the rat

    Article • Clinical and Experimental Pharmacology and Physiology, February 1979, Wiley

    Professor william robert adam

  44. INCREASED RENAL SENSITIVITY TO ALDOSTERONE IN THE RAT: INDUCTION BY A HIGH POTASSIUM DIET

    Article • Clinical and Experimental Pharmacology and Physiology, June 1977, Wiley

    Professor william robert adam

  45. 16α,18-dihydroxydeoxycorticosterone and the binding of aldosterone to mineralocorticoid receptors in kidney of adrenalectomized rats

    Article • Journal of Steroid Biochemistry, May 1976, Elsevier

    Professor william robert adam

  46. Renal mitochondrial glutamine metabolism and dietary potassium and protein content

    Article • Kidney International, May 1975, Elsevier

    Professor william robert adam

  47. BIOCHEMICAL HETEROGENEITY OF GLUTAMINE METABOLISM OF RAT KIDNEY MITOCHONDRIA SEPARATED BY RATE ZONAL CENTRIFUGATION

    Article • Immunology and Cell Biology, April 1975, Wiley

    Professor william robert adam

  48. Glutamine Transport in Rat Kidney Mitochondria in Metabolic Acidosis

    Article • Journal of Clinical Investigation, July 1974, American Society for Clinical Investigation

    Professor william robert adam